Canada as America’s Pharmacy

The article proposes turning Canada into a quasi 'pharma‑state' that mass‑produces and exports drugs to the U.S., leveraging compulsory licensing or policy changes to sell at scale to Americans. Canadians would collect the rents while U.S. consumers get cheaper medicines, sidestepping MFN distortions that impede price discrimination and generic diffusion. — It reframes drug pricing as a cross‑border industrial strategy, implicating trade, intellectual property, and health policy in North America.